miRNA-214 to predict progression and survival in ALS

Key Points

• miRNA-214 indicates potential progression and survival outcomes in ALS, helping to assess disease severity.
• In an observational analysis, increased miRNA-214 levels correlate with poorer survival in ALS patients over two years.
• Utilizing biomarkers, the study identifies miRNA-214's critical role in regulatory pathways impacting ALS progression.
• Findings highlight the significance of miRNA-214 as a potential therapeutic target for enhancing ALS management.